We are live on ! Find out more
FCMI

Foresite Capital Management IV Portfolio holdings

AUM $237M
1-Year Est. Return 107.53%
This Fund
S&P 500
This Quarter Est. Return
-14.31%
1 Year Est. Return
+107.53%
3 Year Est. Return
+149.4%
5 Year Est. Return
+13.8%
10 Year Est. Return
–
AUM
$357M
AUM Growth
-$129M
Cap. Flow
-$16.6M
Cap. Flow %
-4.66%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
3
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ACRS icon
Aclaris Therapeutics
ACRS
+$6.82M
2
HLTH
Cue Health Inc. Common Stock
HLTH
+$6.72M
3
NRIX icon
Nurix Therapeutics
NRIX
+$3.11M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KNTE
1
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$109M 30.47%
9,671,643
– –
LYEL icon
2
Lyell Immunopharma
LYEL
$317M
$67.1M 18.77%
664,109
– –
PHVS icon
3
Pharvaris
PHVS
$2.28B
$59.2M 16.55%
3,261,926
– –
ACRS icon
4
Aclaris Therapeutics
ACRS
$726M
$50M 13.98%
2,899,034
-500,000
-15% -$6.82M
KURA icon
5
Kura Oncology
KURA
$800M
$29.7M 8.32%
1,849,947
– –
QSI icon
6
Quantum-Si Incorporated
QSI
$155M
$20.9M 5.84%
4,463,619
– –
NRIX icon
7
Nurix Therapeutics
NRIX
$2.41B
$14.4M 4.04%
1,030,798
-175,000
-15% -$3.11M
CBAY
8
DELISTED
Cymabay Therapeutics
CBAY
$5.56M 1.55%
1,787,094
– –
HLTH
9
DELISTED
Cue Health Inc. Common Stock
HLTH
$1.7M 0.48%
263,578
-742,511
-74% -$6.72M

Similar funds

BCM
Birmingham Capital Management Birmingham, Alabama $237M AUM 32.7% 1-Year Est. Return
AG
ASO Group Road Town $237M AUM
FL
FreeGulliver LLC New Orleans, Louisiana $237M AUM 21.92% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
MFA
Millington Financial Advisors Naperville, Illinois $237M AUM 22.22% 1-Year Est. Return
TCM
Tekne Capital Management New York $237M AUM 62.98% 1-Year Est. Return
WW
Windle Wealth Oklahoma City, Oklahoma $237M AUM 22.79% 1-Year Est. Return
CB
CNB Bank Clearfield, Pennsylvania $238M AUM 26.55% 1-Year Est. Return

Foresite Capital Management IV's Q1 2022 Portfolio in Review

As of Q1 2022, Foresite Capital Management IV held 9 positions worth $357M, down 26% from $486M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management IV withdrew a net $16.6M in Q1 2022, reducing 3 holdings. Its largest reduction was Aclaris Therapeutics, cutting an estimated $6.82M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management IV's biggest Q1 2022 reduction was Aclaris Therapeutics, cutting an estimated $6.82M.
  • Foresite Capital Management IV's ten largest holdings make up 100% of its $357M portfolio in Q1 2022.
  • Foresite Capital Management IV opened 0 new positions and closed 0 in Q1 2022.
  • Foresite Capital Management IV's portfolio value fell 26% quarter-over-quarter to $357M.

Based on Foresite Capital Management IV's 13F filing for Q1 2022, filed 13 May 2022.